Page tree
Skip to end of metadata
Go to start of metadata

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 42 Next »


CodeX (the Common Oncology Data Elements eXtensions) is an HL7 FHIR Accelerator project building a community to accelerate interoperable data modeling and applications based on a common language for cancer data (mCODE, the minimal Common Oncology Data Elements and extensions for particular use cases). 

Adoption of a common language for cancer will lead to step-change improvements in cancer care and research benefiting all cancer patients. 

For background, read on here. Subscribe to the general mailing Listserv below to keep up to date on general news about CodeX.

Use Cases

A number of initial Use Cases are now in the "Discovery" phase. These are Use Cases that promise to substantially improvements in cancer care and research, provided the community could agree on the use of mCODE and necessary extensions.  Current and prospective CodeX members are starting to build these out. Contact Steve Bratt or Greg Shemancik to get involved.


We are talking with tens of organizations interested in joining CodeX. Our Founding members will be released shortly.  Contact Steve Bratt or Greg Shemancik to discuss membership.


Building a community to accelerate a common language for cancer data requires a lot of community support. As the CodeX initiative rolls out, we will document here the roles and responsibilities of

  • Overall Program Management
  • Steering Committee
  • Operating Committee
  • Architectural Oversight
  • Training


Coming Soon

Site Contents

Since last October’s Cancer Data Summit, we’ve made substantial progress in our goal to enable interoperability across cancer patient data and systems. Using mCODE™ to collect, share, and extract data from EHRs means that every interaction between a clinician and cancer patient provides data that could be used to improve care for all future patients.
MITRE and the  HL7® FHIR® Accelerator CodeX Community invite you to a unique MITRE Listening Session on oncology clinical pathways and prior authorization of cancer therapies on June 26, 2020 from 10:00-11:30 EDT.  Oncology is a dynamic specialty with a rapid expansion of new therapies and tumor genomics.  Over the past five years the use of oncology clinical pathways became a standard approach to assist oncologists in treatment recommendations.…
Thanks to presenters Dr. Lawrence Shulman, Dr. Peter Gabriel of UPenn, Melanie Combs-Dyer - Director of Innovation at Mettle Solutions and Tyler Haydell - Senior Product Manager at Flatiron Health. The slides and a recording of the meeting can be found here. Please join the July 31, 2020 CodeX mCODE Community of Practice meeting on July 31, 2020, noon, where we will discuss the CodeX Oncology Clinical Pathways: Prior Authorization use case. We hope to see you there!


Position: CodeX Program Manager

Position: Deputy CodeX Lead

Position: Technical Lead

Position: Deputy CodeX Tech Lead

Position: Scrum Master

  • No labels